Blue Owl Capital Holdings LP

Holdings History for Tourmaline Bio, Inc. - Common stock, par value $0.0001 per share (TRML)

Symbol: TRML
Investment type: Equity / Common stock, par value $0.0001 per share
Latest Disclosed Shares Owned: 1,079,321 shares
Security Ownership %: 4.2%

Shares, Excluding Options vs Price

Value, Excluding Options

Blue Owl Capital Holdings LP ownership in Tourmaline Bio, Inc. Common stock, par value $0.0001 per share (TRML)

14 Feb 2025 - Blue Owl Capital Holdings LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 1,079,321 shares of Tourmaline Bio, Inc. Common stock, par value $0.0001 per share (TRML). This represents 4.2% ownership of the company. This is the first filing by Blue Owl Capital Holdings LP disclosing ownership of Tourmaline Bio, Inc. Common stock, par value $0.0001 per share (TRML).

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Blue Owl Capital Holdings LP	4.2%		$18,693,840	1,079,321			$17.32	13G/A	31 Dec 2024	14 Feb 2025, 17:09

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Sep 2025		-5.1%	$0	0	-997,107	-100%	$47.98	Q3 2025
30 Jun 2025	5.1%	-0.21%	$15,943,741	997,107	-40,000	-3.9%	$15.99	Q2 2025
31 Mar 2025	5.1%	-0.21%	$15,774,397	1,037,107	-42,214		$15.21	Q1 2025
31 Dec 2024	5.2%	-2.2%	$21,888,630	1,079,321	-451,080	-29%	$20.28	Q4 2024
30 Sep 2024	7.6%	-0.92%	$39,346,610	1,530,401	-185,000	-11%	$25.71	Q3 2024
30 Jun 2024	6.2%	+0.78%	$22,060,057	1,715,401	+268,000	+19%	$12.86	Q2 2024
31 Mar 2024	7.2%	+0.57%	$31,994,641	1,447,401	+115,099	+8.6%	$22.10	Q1 2024
31 Dec 2023	8.1%	+8.1%	$32,394,496	1,332,302	+1,332,302	NEW	$24.31	Q4 2023

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.